Long Life Unlimited

CLOSEOUT LETTER Long Life Unlimited MARCS-CMS 533282 — February 17, 2022 More Warning Letters Warning Letters About Warning and Close-Out Letters Product: Dietary Supplements Recipient: Recipient Name Barbara A. Long Long Life Unlimited 328 E. Kirby St. Lima , OH 45804 United States Issuing Office: Cincinnati District Office United States Dear Ms. Long: The Food and Drug Administration has completed evaluation of your corrective actions in response to our Warning Letter 533282 issued on January 31, 2018. Based on our evaluation of your website: www.longlifeunlimited.com on January 31, 2022, it appears that you have addressed the violations contained in the Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. /S/ Stephen J. Rabe Compliance Officer Content current as of: 02/25/2022 Regulated Product(s) Dietary Supplements